Morgan Stanley’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Morgan Stanley’s Portfolio XAGE Stock Details XAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-467	Closed	-$1.75K	–	8333
2025 Q1	$1.75K	Hold	467	–	–	﹤0.01%	7199
2024 Q4	$3.91K	Buy	467 +398	+577%	+$3.78K	﹤0.01%	7071
2024 Q3	$836	Hold	69	–	–	﹤0.01%	7251
2024 Q2	$2.77K	Hold	69	–	–	﹤0.01%	7000
2024 Q1	$5.33K	Sell	69 -70	-50%	-$6.64K	﹤0.01%	6878
2023 Q4	$15.9K	Buy	139 +70	+101%	+$5.98K	﹤0.01%	6728
2023 Q3	$7.5K	Buy	+69	New	+$10.4K	﹤0.01%	6814

Other funds holding XAGE

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CMU

Carnegie Mellon University Pittsburgh, Pennsylvania $64.3M AUM 35.71% 1-Year Est. Return

GSWM

Golden State Wealth Management Santa Ana, California $915M AUM 19.16% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Morgan Stanley's XAGE Position: Q2 2025 in Review

Morgan Stanley sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q2 2025, closing a stake of 467 shares — an estimated $1.75K sold.

Morgan Stanley first reported a position in XAGE in Q3 2023 and held it in 7 quarters. The position peaked at $15.9K in Q4 2023. 11 funds tracked by Wall St. Rank hold XAGE as of Q2 2025.

Morgan Stanley reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Morgan Stanley sold 467 Longevity Health Holdings, Inc. Common Stock shares in Q2 2025, an estimated $1.75K.
Morgan Stanley first reported a position in Longevity Health Holdings, Inc. Common Stock in Q3 2023 and held it in 7 quarters.
Morgan Stanley's Longevity Health Holdings, Inc. Common Stock position peaked at $15.9K in Q4 2023.
11 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q2 2025.

Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.